Hanshen Yang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma.

Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma.

Journal: Science advances

Published: May 21, 2025

A bioorthogonal nanoconcentrisome system for epigenetic and immunometabolic reprogramming of tissue regeneration in aged female rats.

A bioorthogonal nanoconcentrisome system for epigenetic and immunometabolic reprogramming of tissue regeneration in aged female rats.

Journal: Nature communications

Published: December 13, 2024

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Journal: Nature communications

Published: November 26, 2024

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

Journal: The Journal of clinical investigation

Published: September 12, 2024

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy.

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy.

Journal: Cancer communications (London, England)

Published: June 10, 2024

Spatiotemporal-adaptive nanotherapeutics promote post-injury regeneration in ageing through metabolic modulation.

Spatiotemporal-adaptive nanotherapeutics promote post-injury regeneration in ageing through metabolic modulation.

Journal: Nature nanotechnology

Published: May 21, 2024

Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma.

Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma.

Journal: Cell reports. Medicine

Published: February 16, 2024

Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance.

Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance.

Journal: Autophagy

Published: January 04, 2024

Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.

Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: July 14, 2023

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma.

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma.

Journal: Computational and structural biotechnology journal

Published: June 05, 2023

Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy.

Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 26, 2023

The "Self-eating" of cancer-associated fibroblast: A potential target for cancer.

The "Self-eating" of cancer-associated fibroblast: A potential target for cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 25, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026